3 Surefire Growth Stocks Destined to Double in Value

Remember March 2020? Back then, most people wanted no part of the stock market. COVID-19 had jest been designated a pandemic, travel at all levels was grinding to a halt, and major stock indexes were in a deep dive. 

But those who kept their heads, invested money in a Nasdaq Composite index fund, and patiently waited saw a big reward less than a year later: Their investment had doubled in value. Between March 20, 2020, and Feb. 12, 2021, the index posted a 105% gain.

Today, opportunities can again be found with the Nasdaq Composite trading down 24% year to date and many individual stocks down much further. There’s no guarantee of a one-year doubling this time around, but there is definitely potential for solid returns. Let’s look at three growth stocks that I think are destined to double from current valuations.

1. Snowflake 

Snowflake (NYSE: SNOW) went public in 2020 and is led by Frank Slootman, who formerly was chairman of enterprise software giant ServiceNow. Snowflake’s signature product is Data Cloud, which helps customers aggregate all of their data in a central location, allowing them to innovate, achieve efficiencies, and gain insights into their business.

It’s still early days for the company, which has only $1.4 billion in revenue over the last 12 months, but its revenue and customer base are growing rapidly. Fiscal 2023 first-quarter revenue was up 85% year over year; total customers surged to more than 6,000.

Investors are taking notice. Warren Buffett is a believer; his Berkshire Hathaway owns over 6 million shares of Snowflake, worth around $875 million.

Analysts expect Snowflake to continue growing for years. According to Wall Street, revenue should rise 66% this year and 53% the following year.

With a forecast for that much growth, Snowflake stock could easily double its value in the next few years.

2. Alphabet

There are plenty of reasons to like Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) right now, like its attractive price/earnings-to-growth ratio, its recent stock split, and its impressive share of the digital ad market.

And there’s Alphabet’s tremendous growth rate for a company of its size. Quarterly revenue is up around 20% year over year.

The company produced $277 billion of revenue over the last 12 months, putting it eighth among U.S. companies, and closing in on ExxonMobilCVS, and UnitedHealth Group

And Wall Street thinks Alphabet can keep the growth going for years to come. Consensus estimates are for revenue increases of 14% annually for the next five years.

3. Zoetis 

My third stock destined to double is Zoetis (NYSE: ZTS), a veterinary drugmaker. It produces pharmaceuticals for livestock and companion animals. 

Roughly two-thirds of sales are from its companion-animals segment. Revenue from this part of the business is also growing faster, around 20% year over year.

The company is well positioned to benefit from the long-term growth of the pet market. Morgan Stanley estimates that overall pet spending in the U.S. will more than double to $275 billion by 2030. With over half (66%) of U.S. households owning a pet, according to Morgan Stanley’s research, and nearly half (47%) of respondents saying that they treat their pets like they treat their child, the amount spent on pet healthcare is certain to rise in the coming years.

Wall Street expects Zoetis to profit from this trend. The company already has a robust operating margin of 36%, and a solid return on equity of 47%. Analysts anticipate it will grow earnings by 11% annually over the next five years.

As it rides the tailwinds of increased pet spending, I think Zoetis could easily double over the next five to 10 years.

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Jake Lerch has positions in Alphabet (C shares). The Motley Fool has positions in and recommends Alphabet (A shares), Alphabet (C shares), Berkshire Hathaway (B shares), ServiceNow, Inc., Snowflake Inc., and Zoetis. The Motley Fool recommends CVS Health, CVS Health Corporation, and UnitedHealth Group and recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Rebate Rewards

Level 2 Rebate

Deposit $2,000 and get $200 Rebate
$ 200 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $2,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $200 Rebate

Level 1 Rebate

Deposit $1,000 and get $100 Rebate
$ 100 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $1,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $100 Rebate

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Act Fast - Promotion Ends In
Click Here To Get Started
Act Fast - Promotion Ends In
Click Here For More Info